SSD AF Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ssd Af, and what generic alternatives are available?
Ssd Af is a drug marketed by Dr Reddys La and is included in one NDA.
The generic ingredient in SSD AF is silver sulfadiazine. There are twenty-two drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the silver sulfadiazine profile page.
Summary for SSD AF
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 54 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SSD AF at DailyMed |
Pharmacology for SSD AF
Drug Class | Sulfonamide Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for SSD AF
US Patents and Regulatory Information for SSD AF
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dr Reddys La | SSD AF | silver sulfadiazine | CREAM;TOPICAL | 018578-003 | Jul 11, 1990 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |